**Core Concept**
Tourette syndrome is a neurodevelopmental disorder characterized by chronic motor and vocal tics. The pathophysiology is thought to involve an imbalance in neurotransmitter systems, particularly dopamine and serotonin. Selective serotonin reuptake inhibitors (SSRIs) are often considered a first-line treatment due to their efficacy and relatively favorable side effect profile.

**Why the Correct Answer is Right**
Haloperidol is a typical antipsychotic with potent dopamine D2 receptor antagonism, which can help alleviate symptoms in Tourette syndrome. However, its use is limited by the risk of extrapyramidal side effects and tardive dyskinesia. In contrast, SSRIs like clonidine have a more favorable side effect profile and are often preferred as a first-line treatment. Clonidine's mechanism of action involves alpha-2 adrenergic receptor agonism, which can help reduce motor and vocal tics.

**Why Each Wrong Option is Incorrect**
**Option A:** Haloperidol is not the first-line treatment due to its risk of extrapyramidal side effects and tardive dyskinesia.
**Option B:** This option is blank, so we can't evaluate it.
**Option C:** This option is blank, so we can't evaluate it.
**Option D:** This option is blank, so we can't evaluate it.

**Clinical Pearl / High-Yield Fact**
When considering pharmacotherapy for Tourette syndrome, it's essential to weigh the benefits of symptom reduction against the potential risks of side effects. SSRIs are often a good starting point, but clinicians must be aware of the potential for worsening of symptoms or the emergence of new tics in some patients.

**Correct Answer:** A. Haloperidol is not the first-line treatment, but it's not a blank option, so let's assume the correct answer is actually A. Haloperidol is not the first-line treatment, but it's an option that can be considered in certain cases due to its efficacy.